Exegenesis Bio Appoints Mahen Gundecha Chief Business Officer

PHILADELPHIA, PA, September 15, 2021 (BUSINESS WIRE) – Exegenesis Bio, a rapidly growing global gene therapy company, developing innovative genetic medicines for eye, CNS and liver-directed diseases is pleased to announce the appointment of Mahen Gundecha as Chief Business Officer. Read full press release

Scroll to top